| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/10/1999 | WO1999044634A1 Il-12 stimulation of neonatal immunity |
| 09/10/1999 | WO1999044633A1 Live recombined vaccines injected with adjuvant |
| 09/10/1999 | WO1999044629A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 09/10/1999 | WO1999044620A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/10/1999 | WO1999044607A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of autoimmune diseases |
| 09/10/1999 | WO1999044602A1 Inflammatory cell inhibitors |
| 09/10/1999 | WO1999044584A1 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 09/10/1999 | WO1999033793A3 Prodrugs of aspartyl protease inhibitors |
| 09/10/1999 | WO1999027958A9 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/10/1999 | WO1999027948A3 Use of soluble recombinant human cd40l protein for inhibiting in vivo immune response |
| 09/10/1999 | WO1999013907A9 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 09/10/1999 | CA2323176A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of autoimmune diseases |
| 09/10/1999 | CA2322749A1 Cd147 binding molecules as therapeutics |
| 09/10/1999 | CA2322712A1 Method for activating natural killer (nk) cells |
| 09/10/1999 | CA2322684A1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 09/10/1999 | CA2322665A1 Delivery of proteins into eukaryotic cells with recombinant yersinia |
| 09/10/1999 | CA2322486A1 Inflammatory cell inhibitors |
| 09/10/1999 | CA2322337A1 Enhancement of immunity by intranasal inoculation of il-12 |
| 09/10/1999 | CA2322336A1 Il-12 stimulation of neonatal immunity |
| 09/10/1999 | CA2322294A1 Il-12 enhancement of immune responses to t-independent antigens |
| 09/10/1999 | CA2265069A1 Oral immunity enhancing agent |
| 09/10/1999 | CA2264970A1 Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria |
| 09/08/1999 | EP0940391A2 Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 09/08/1999 | EP0940142A2 Use of PKC inhibitors for the manufacture of a medicament for the treatment of autoimmune diseases |
| 09/08/1999 | EP0939822A2 Use of mutated macrolide binding protein for the prevention of guhd |
| 09/08/1999 | EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 09/08/1999 | EP0939817A2 High-affinity interleukin-4 muteins |
| 09/08/1999 | EP0939812A2 Novel human macrophage antigen |
| 09/08/1999 | EP0939807A2 Secreted proteins and polynucleotides encoding them |
| 09/08/1999 | EP0939804A1 NEUTROKINE alpha |
| 09/08/1999 | EP0939654A1 Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 09/08/1999 | EP0939653A1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 09/08/1999 | EP0939652A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation |
| 09/08/1999 | EP0939643A1 Immunomodulating compounds comprising d-isomers of amino acids |
| 09/08/1999 | EP0939642A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 09/08/1999 | EP0706393B1 Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone |
| 09/08/1999 | EP0656906B1 A novel endothelial cell molecule mediating lymphocyte binding in man |
| 09/08/1999 | CN1228091A Substituted 6,6-hetero-bicyclic derivatives |
| 09/08/1999 | CN1228090A Naphthyridines with affect IL-4 and G-CSF |
| 09/08/1999 | CN1227871A Nuclein structural body for gene treating method |
| 09/07/1999 | US5948813 Method of preventing allograft rejection |
| 09/07/1999 | US5948778 Difluoro statone antiviral analogs |
| 09/07/1999 | US5948777 Cannabinoid receptor agonists |
| 09/07/1999 | US5948758 Methods for treating various disease states by reducing adhesion of leukocytes of target cells |
| 09/07/1999 | US5948693 Solid phase synthesis of immunosuppressive agents |
| 09/07/1999 | US5948657 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 09/07/1999 | US5948642 Polynucleotide from staphylococcus aureus which codes for resolvase polypeptide; for diagnosis of infections; as bactericides; for screening for novel antibiotics; treatment of toxic shock syndrome |
| 09/07/1999 | US5948442 Nucleoside, low and high molecular weight peptides, activation of biosynthesis of nucleic aics and specific proteins |
| 09/07/1999 | US5948436 Protease inhibitor |
| 09/07/1999 | US5948412 Vaccine for Moraxella catarrhalis |
| 09/07/1999 | US5948410 Animal cell culture |
| 09/07/1999 | US5948409 T cell receptor ligands and methods of using same |
| 09/07/1999 | US5948407 Oral induction of tolerance to parenterally administered non-autologous polypeptides |
| 09/07/1999 | US5948406 N-tert-butyldibenzoylhydrazine derivatives |
| 09/07/1999 | CA2138765C Recombinant haemophilus influenzae protein and nucleotide sequence encoding same |
| 09/07/1999 | CA2098944C Novel pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 09/07/1999 | CA2016646C Arylsulphonamides |
| 09/07/1999 | CA2006119C Anti-aids viral agents and anticancer action |
| 09/07/1999 | CA1340729C Ryegrass pollen allergen |
| 09/02/1999 | WO1999043839A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | WO1999043832A2 Human proteinase molecules |
| 09/02/1999 | WO1999043829A2 Cell cycle related proteins |
| 09/02/1999 | WO1999043814A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 09/02/1999 | WO1999043805A1 Human protein kinase c inhibitor |
| 09/02/1999 | WO1999043693A1 36 human secreted proteins |
| 09/02/1999 | WO1999043692A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE |
| 09/02/1999 | WO1999043680A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | WO1999043642A1 Phenylalanine derivatives as inhibitors of alpha4 integrins |
| 09/02/1999 | WO1999043351A1 Novel multitarget drugs and therapeutic applications |
| 09/02/1999 | WO1999043350A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin |
| 09/02/1999 | WO1999043348A1 Immunostimulation methods for providing disease protection in poultry |
| 09/02/1999 | WO1999043346A1 Methods for diagnosing and treating autoimmune disease |
| 09/02/1999 | WO1999043345A1 Amino acid degrading enzymes modulate cell death |
| 09/02/1999 | WO1999043334A1 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 09/02/1999 | WO1999043220A1 Product and method to reduce stress induced immune suppression |
| 09/02/1999 | WO1999043208A1 The helios gene |
| 09/02/1999 | WO1999033488A3 Adjuvanted vaccine formulation |
| 09/02/1999 | WO1999030720A8 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 09/02/1999 | WO1999023105A9 Vegi, an inhibitor of angiogenesis and tumor growth |
| 09/02/1999 | WO1998030693A9 Tumor necrosis factor receptor 5 |
| 09/02/1999 | CA2792479A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2322160A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2321993A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 09/02/1999 | CA2321970A1 36 human secreted proteins |
| 09/02/1999 | CA2321959A1 Methods for diagnosing and treating autoimmune disease |
| 09/02/1999 | CA2321870A1 Cell cycle related proteins |
| 09/02/1999 | CA2321869A1 Human proteinase molecules |
| 09/02/1999 | CA2321746A1 Human protein kinase c inhibitor |
| 09/02/1999 | CA2321559A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/01/1999 | EP0939127A2 Humanized immunoglobulins and their production and use |
| 09/01/1999 | EP0939121A2 TNF-binding proteins |
| 09/01/1999 | EP0939082A1 Protein polysaccharide 0041 |
| 09/01/1999 | EP0938500A1 INTERLEUKIN-1beta-CONVERTING ENZYME (ICE) INHIBITING PEPTIDES |
| 09/01/1999 | EP0938498A1 Multivalent compounds for cross-linking receptors and uses thereof |
| 09/01/1999 | EP0938496A1 Heptapeptide oxytocin analogues |
| 09/01/1999 | EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/01/1999 | EP0938345A1 Aqueous-based pharmaceutical composition |
| 09/01/1999 | EP0938334A1 Improved method of treating immune cell mediated systemic diseases |
| 09/01/1999 | EP0938328A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 09/01/1999 | EP0938327A1 Method of inhibiting the release of bioactive il-1 |